Enolase (Malay Wikipedia)

Analysis of information sources in references of the Wikipedia article "Enolase" in Malay language version.

refsWebsite

Global rank Malay rank

51nih.gov

4^th place

14^th place

37doi.org

2^nd place

8^th place

17wikipedia.org

low place

5harvard.edu

18^th place

46^th place

2rcsb.org

8,838^th place

3,329^th place

doi.org

PDB: 2ONE; Zhang E, Brewer JM, Minor W, Carreira LA, Lebioda L (October 1997). "Mechanism of enolase: the crystal structure of asymmetric dimer enolase-2-phospho-D-glycerate/enolase-phosphoenolpyruvate at 2.0 A resolution". Biochemistry. 36 (41): 12526–12534. doi:10.1021/bi9712450. PMID 9376357.
"Multifunctional alpha-enolase: its role in diseases". Cellular and Molecular Life Sciences. 58 (7): 902–920. June 2001. doi:10.1007/pl00000910. PMID 11497239.
"Purification and properties of enolase of human erythrocytes". International Journal of Biochemistry. 5 (11–12): 845–852. November 1974. doi:10.1016/0020-711X(74)90119-0. |hdl-access= requires |hdl= (bantuan)
"Molecular structure of the human muscle-specific enolase gene (ENO3)". The Biochemical Journal. 275 ( Pt 2) (Pt 2): 427–433. April 1991. doi:10.1042/bj2750427. PMC 1150071. PMID 1840492.
"Plasmin(ogen)-binding alpha-enolase from Streptococcus pneumoniae: crystal structure and evaluation of plasmin(ogen)-binding sites". Journal of Molecular Biology. 343 (4): 997–1005. October 2004. doi:10.1016/j.jmb.2004.08.088. PMID 15476816.
"Crystal structure of an efficacious gonococcal adherence inhibitor: an enolase from Lactobacillus gasseri". FEBS Letters. 588 (14): 2212–2216. June 2014. doi:10.1016/j.febslet.2014.05.020. PMID 24859038.
"Isotopic probes of the enolase reaction mechanism". J Biol Chem. 240 (14): 4586–93. 1971. doi:10.1016/S0021-9258(18)62051-4.
"Toward identification of acid/base catalysts in the active site of enolase: comparison of the properties of K345A, E168Q, and E211Q variants". Biochemistry. 35 (5): 1692–1699. February 1996. doi:10.1021/bi952186y. PMID 8634301.
"Structural and mechanistic studies of enolase". Current Opinion in Structural Biology. 6 (6): 736–743. December 1996. doi:10.1016/S0959-440X(96)80002-9. PMID 8994873.
"Octahedral coordination at the high-affinity metal site in enolase: crystallographic analysis of the MgII--enzyme complex from yeast at 1.9 A resolution". Biochemistry. 34 (13): 4325–4330. April 1995. doi:10.1021/bi00013a022. PMID 7703246.
"Chelation of serine 39 to Mg2+ latches a gate at the active site of enolase: structure of the bis(Mg2+) complex of yeast enolase and the intermediate analog phosphonoacetohydroxamate at 2.1-A resolution". Biochemistry. 33 (31): 9333–9342. August 1994. doi:10.1021/bi00197a038. PMID 8049235.
"A carboxylate oxygen of the substrate bridges the magnesium ions at the active site of enolase: structure of the yeast enzyme complexed with the equilibrium mixture of 2-phosphoglycerate and phosphoenolpyruvate at 1.8 A resolution". Biochemistry. 35 (14): 4349–4358. April 1996. doi:10.1021/bi952859c. PMID 8605183.
"X-ray structure and catalytic mechanism of lobster enolase". Biochemistry. 34 (39): 12513–12523. October 1995. doi:10.1021/bi00039a005. PMID 7547999.
"Levels of enolase and other enzymes in the cerebrospinal fluid as indices of pathological change". Journal of Neurology, Neurosurgery, and Psychiatry. 44 (12): 1129–1135. December 1981. doi:10.1136/jnnp.44.12.1129. PMC 491233. PMID 7334408.
"Neurological outcome after out-of-hospital cardiac arrest. Prediction by cerebrospinal fluid enzyme analysis". Archives of Neurology. 46 (7): 753–756. July 1989. doi:10.1001/archneur.1989.00520430047015. PMID 2742544.
"Cerebrospinal fluid enolase in stroke". Journal of Neurology, Neurosurgery, and Psychiatry. 47 (7): 724–729. July 1984. doi:10.1136/jnnp.47.7.724. PMC 1027902. PMID 6747647.
"Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase". Arthritis and Rheumatism. 58 (10): 3009–3019. October 2008. doi:10.1002/art.23936. PMID 18821669. Unknown parameter |displayauthors= ignored (bantuan)
"Autoantibodies against the amino terminal of alpha-enolase are a useful diagnostic marker of Hashimoto's encephalopathy". Journal of Neuroimmunology. 162 (1–2): 130–136. May 2005. doi:10.1016/j.jneuroim.2005.02.004. PMID 15833368. Unknown parameter |displayauthors= ignored (bantuan)
"Reaction intermediate analogues for enolase". Biochemistry. 23 (12): 2779–2786. June 1984. doi:10.1021/bi00307a038. PMID 6380574.
"A unique small molecule inhibitor of enolase clarifies its role in fundamental biological processes". ACS Chemical Biology. 8 (6): 1271–1282. 2 April 2013. doi:10.1021/cb300687k. PMID 23547795. Unknown parameter |displayauthors= ignored (bantuan)
"Structure of the bis divalent cation complex with phosphonoacetohydroxamate at the active site of enolase". Biochemistry. 31 (31): 7166–7173. August 1992. doi:10.1021/bi00146a020. PMID 1322695.
"Catalytic metal ion binding in enolase: the crystal structure of an enolase-Mn2+-phosphonoacetohydroxamate complex at 2.4-A resolution". Biochemistry. 33 (20): 6295–6300. May 1994. doi:10.1021/bi00186a032. PMID 8193144.
"Structural flexibility in Trypanosoma brucei enolase revealed by X-ray crystallography and molecular dynamics". The FEBS Journal. 274 (19): 5077–5089. October 2007. doi:10.1111/j.1742-4658.2007.06027.x. PMID 17822439. Unknown parameter |displayauthors= ignored (bantuan)
"Passenger deletions generate therapeutic vulnerabilities in cancer". Nature. 488 (7411): 337–342. August 2012. Bibcode:2012Natur.488..337M. doi:10.1038/nature11331. PMC 3712624. PMID 22895339. Unknown parameter |displayauthors= ignored (bantuan)
"SF2312 is a natural phosphonate inhibitor of enolase". Nature Chemical Biology. 12 (12): 1053–1058. December 2016. doi:10.1038/nchembio.2195. PMC 5110371. PMID 27723749. Unknown parameter |displayauthors= ignored (bantuan)
"Functional and structural basis of E. coli enolase inhibition by SF2312: a mimic of the carbanion intermediate". Scientific Reports. 9 (1): 17106. November 2019. Bibcode:2019NatSR...917106K. doi:10.1038/s41598-019-53301-3. PMC 6863902. PMID 31745118. Unknown parameter |displayauthors= ignored (bantuan)
"The 3S Enantiomer Drives Enolase Inhibitory Activity in SF2312 and Its Analogues". Molecules. 24 (13): 2510. July 2019. doi:10.3390/molecules24132510. PMC 6651268. PMID 31324042. Unknown parameter |displayauthors= ignored (bantuan)
"An enolase inhibitor for the targeted treatment of ENO1-deleted cancers". Nature Metabolism. 2 (12): 1413–1426. December 2020. doi:10.1038/s42255-020-00313-3. PMC 7744354. PMID 33230295. Unknown parameter |displayauthors= ignored (bantuan)
"ENOblock Does Not Inhibit the Activity of the Glycolytic Enzyme Enolase". PLOS ONE. 11 (12): e0168739. 28 December 2016. Bibcode:2016PLoSO..1168739S. doi:10.1371/journal.pone.0168739. PMC 5193436. PMID 28030597.
"ENOblock, a unique small molecule inhibitor of the non-glycolytic functions of enolase, alleviates the symptoms of type 2 diabetes". Scientific Reports. 7: 44186. March 2017. Bibcode:2017NatSR...744186C. doi:10.1038/srep44186. PMC 5341156. PMID 28272459. Unknown parameter |displayauthors= ignored (bantuan)
"Inhibition of human muscle-specific enolase by methylglyoxal and irreversible formation of advanced glycation end products". Journal of Enzyme Inhibition and Medicinal Chemistry. 24 (2): 356–364. April 2009. doi:10.1080/14756360802187679. PMID 18830874.
"Targeting Host Glycolysis as a Strategy for Antimalarial Development". Frontiers in Cellular and Infection Microbiology. 11: 730413. 16 September 2021. doi:10.3389/fcimb.2021.730413. PMC 8482815 Check |pmc= value (bantuan). PMID 34604112 Check |pmid= value (bantuan). Unknown parameter |displayauthors= ignored (bantuan)
"Structure-guided microbial targeting of antistaphylococcal prodrugs". eLife. 10: e66657. July 2021. doi:10.7554/eLife.66657. PMC 8318587 Check |pmc= value (bantuan). PMID 34279224. Unknown parameter |displayauthors= ignored (bantuan)
"Antimicrobial Prodrug Activation by the Staphylococcal Glyoxalase GloB". ACS Infectious Diseases. 6 (11): 3064–3075. November 2020. doi:10.1021/acsinfecdis.0c00582. PMC 8543975 Check |pmc= value (bantuan). PMID 33118347. Unknown parameter |displayauthors= ignored (bantuan)
"Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant Melanoma". Cell Reports. 33 (3): 108293. October 2020. doi:10.1016/j.celrep.2020.108293. PMC 7649750. PMID 33086062. Unknown parameter |displayauthors= ignored (bantuan)
"Functional and structural basis of E. coli enolase inhibition by SF2312: a mimic of the carbanion intermediate". Scientific Reports. 9 (1): 17106. November 2019. Bibcode:2019NatSR...917106K. doi:10.1038/s41598-019-53301-3. PMC 6863902. PMID 31745118. Unknown parameter |displayauthors= ignored (bantuan)
"The 3S Enantiomer Drives Enolase Inhibitory Activity in SF2312 and Its Analogues". Molecules. 24 (13): 2510. July 2019. doi:10.3390/molecules24132510. PMC 6651268. PMID 31324042. Unknown parameter |displayauthors= ignored (bantuan)

harvard.edu

ui.adsabs.harvard.edu

"Passenger deletions generate therapeutic vulnerabilities in cancer". Nature. 488 (7411): 337–342. August 2012. Bibcode:2012Natur.488..337M. doi:10.1038/nature11331. PMC 3712624. PMID 22895339. Unknown parameter |displayauthors= ignored (bantuan)
"Functional and structural basis of E. coli enolase inhibition by SF2312: a mimic of the carbanion intermediate". Scientific Reports. 9 (1): 17106. November 2019. Bibcode:2019NatSR...917106K. doi:10.1038/s41598-019-53301-3. PMC 6863902. PMID 31745118. Unknown parameter |displayauthors= ignored (bantuan)
"ENOblock Does Not Inhibit the Activity of the Glycolytic Enzyme Enolase". PLOS ONE. 11 (12): e0168739. 28 December 2016. Bibcode:2016PLoSO..1168739S. doi:10.1371/journal.pone.0168739. PMC 5193436. PMID 28030597.
"ENOblock, a unique small molecule inhibitor of the non-glycolytic functions of enolase, alleviates the symptoms of type 2 diabetes". Scientific Reports. 7: 44186. March 2017. Bibcode:2017NatSR...744186C. doi:10.1038/srep44186. PMC 5341156. PMID 28272459. Unknown parameter |displayauthors= ignored (bantuan)
"Functional and structural basis of E. coli enolase inhibition by SF2312: a mimic of the carbanion intermediate". Scientific Reports. 9 (1): 17106. November 2019. Bibcode:2019NatSR...917106K. doi:10.1038/s41598-019-53301-3. PMC 6863902. PMID 31745118. Unknown parameter |displayauthors= ignored (bantuan)

nih.gov

pubmed.ncbi.nlm.nih.gov

PDB: 2ONE; Zhang E, Brewer JM, Minor W, Carreira LA, Lebioda L (October 1997). "Mechanism of enolase: the crystal structure of asymmetric dimer enolase-2-phospho-D-glycerate/enolase-phosphoenolpyruvate at 2.0 A resolution". Biochemistry. 36 (41): 12526–12534. doi:10.1021/bi9712450. PMID 9376357.
"Multifunctional alpha-enolase: its role in diseases". Cellular and Molecular Life Sciences. 58 (7): 902–920. June 2001. doi:10.1007/pl00000910. PMID 11497239.
"Molecular structure of the human muscle-specific enolase gene (ENO3)". The Biochemical Journal. 275 ( Pt 2) (Pt 2): 427–433. April 1991. doi:10.1042/bj2750427. PMC 1150071. PMID 1840492.
"Plasmin(ogen)-binding alpha-enolase from Streptococcus pneumoniae: crystal structure and evaluation of plasmin(ogen)-binding sites". Journal of Molecular Biology. 343 (4): 997–1005. October 2004. doi:10.1016/j.jmb.2004.08.088. PMID 15476816.
"Crystal structure of an efficacious gonococcal adherence inhibitor: an enolase from Lactobacillus gasseri". FEBS Letters. 588 (14): 2212–2216. June 2014. doi:10.1016/j.febslet.2014.05.020. PMID 24859038.
"Toward identification of acid/base catalysts in the active site of enolase: comparison of the properties of K345A, E168Q, and E211Q variants". Biochemistry. 35 (5): 1692–1699. February 1996. doi:10.1021/bi952186y. PMID 8634301.
"Structural and mechanistic studies of enolase". Current Opinion in Structural Biology. 6 (6): 736–743. December 1996. doi:10.1016/S0959-440X(96)80002-9. PMID 8994873.
"Octahedral coordination at the high-affinity metal site in enolase: crystallographic analysis of the MgII--enzyme complex from yeast at 1.9 A resolution". Biochemistry. 34 (13): 4325–4330. April 1995. doi:10.1021/bi00013a022. PMID 7703246.
"Chelation of serine 39 to Mg2+ latches a gate at the active site of enolase: structure of the bis(Mg2+) complex of yeast enolase and the intermediate analog phosphonoacetohydroxamate at 2.1-A resolution". Biochemistry. 33 (31): 9333–9342. August 1994. doi:10.1021/bi00197a038. PMID 8049235.
"A carboxylate oxygen of the substrate bridges the magnesium ions at the active site of enolase: structure of the yeast enzyme complexed with the equilibrium mixture of 2-phosphoglycerate and phosphoenolpyruvate at 1.8 A resolution". Biochemistry. 35 (14): 4349–4358. April 1996. doi:10.1021/bi952859c. PMID 8605183.
"X-ray structure and catalytic mechanism of lobster enolase". Biochemistry. 34 (39): 12513–12523. October 1995. doi:10.1021/bi00039a005. PMID 7547999.
"Levels of enolase and other enzymes in the cerebrospinal fluid as indices of pathological change". Journal of Neurology, Neurosurgery, and Psychiatry. 44 (12): 1129–1135. December 1981. doi:10.1136/jnnp.44.12.1129. PMC 491233. PMID 7334408.
"Neurological outcome after out-of-hospital cardiac arrest. Prediction by cerebrospinal fluid enzyme analysis". Archives of Neurology. 46 (7): 753–756. July 1989. doi:10.1001/archneur.1989.00520430047015. PMID 2742544.
"Cerebrospinal fluid enolase in stroke". Journal of Neurology, Neurosurgery, and Psychiatry. 47 (7): 724–729. July 1984. doi:10.1136/jnnp.47.7.724. PMC 1027902. PMID 6747647.
"Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase". Arthritis and Rheumatism. 58 (10): 3009–3019. October 2008. doi:10.1002/art.23936. PMID 18821669. Unknown parameter |displayauthors= ignored (bantuan)
"Autoantibodies against the amino terminal of alpha-enolase are a useful diagnostic marker of Hashimoto's encephalopathy". Journal of Neuroimmunology. 162 (1–2): 130–136. May 2005. doi:10.1016/j.jneuroim.2005.02.004. PMID 15833368. Unknown parameter |displayauthors= ignored (bantuan)
"Reaction intermediate analogues for enolase". Biochemistry. 23 (12): 2779–2786. June 1984. doi:10.1021/bi00307a038. PMID 6380574.
"A unique small molecule inhibitor of enolase clarifies its role in fundamental biological processes". ACS Chemical Biology. 8 (6): 1271–1282. 2 April 2013. doi:10.1021/cb300687k. PMID 23547795. Unknown parameter |displayauthors= ignored (bantuan)
"Structure of the bis divalent cation complex with phosphonoacetohydroxamate at the active site of enolase". Biochemistry. 31 (31): 7166–7173. August 1992. doi:10.1021/bi00146a020. PMID 1322695.
"Catalytic metal ion binding in enolase: the crystal structure of an enolase-Mn2+-phosphonoacetohydroxamate complex at 2.4-A resolution". Biochemistry. 33 (20): 6295–6300. May 1994. doi:10.1021/bi00186a032. PMID 8193144.
"Structural flexibility in Trypanosoma brucei enolase revealed by X-ray crystallography and molecular dynamics". The FEBS Journal. 274 (19): 5077–5089. October 2007. doi:10.1111/j.1742-4658.2007.06027.x. PMID 17822439. Unknown parameter |displayauthors= ignored (bantuan)
"Passenger deletions generate therapeutic vulnerabilities in cancer". Nature. 488 (7411): 337–342. August 2012. Bibcode:2012Natur.488..337M. doi:10.1038/nature11331. PMC 3712624. PMID 22895339. Unknown parameter |displayauthors= ignored (bantuan)
"SF2312 is a natural phosphonate inhibitor of enolase". Nature Chemical Biology. 12 (12): 1053–1058. December 2016. doi:10.1038/nchembio.2195. PMC 5110371. PMID 27723749. Unknown parameter |displayauthors= ignored (bantuan)
"Functional and structural basis of E. coli enolase inhibition by SF2312: a mimic of the carbanion intermediate". Scientific Reports. 9 (1): 17106. November 2019. Bibcode:2019NatSR...917106K. doi:10.1038/s41598-019-53301-3. PMC 6863902. PMID 31745118. Unknown parameter |displayauthors= ignored (bantuan)
"The 3S Enantiomer Drives Enolase Inhibitory Activity in SF2312 and Its Analogues". Molecules. 24 (13): 2510. July 2019. doi:10.3390/molecules24132510. PMC 6651268. PMID 31324042. Unknown parameter |displayauthors= ignored (bantuan)
"An enolase inhibitor for the targeted treatment of ENO1-deleted cancers". Nature Metabolism. 2 (12): 1413–1426. December 2020. doi:10.1038/s42255-020-00313-3. PMC 7744354. PMID 33230295. Unknown parameter |displayauthors= ignored (bantuan)
"ENOblock Does Not Inhibit the Activity of the Glycolytic Enzyme Enolase". PLOS ONE. 11 (12): e0168739. 28 December 2016. Bibcode:2016PLoSO..1168739S. doi:10.1371/journal.pone.0168739. PMC 5193436. PMID 28030597.
"ENOblock, a unique small molecule inhibitor of the non-glycolytic functions of enolase, alleviates the symptoms of type 2 diabetes". Scientific Reports. 7: 44186. March 2017. Bibcode:2017NatSR...744186C. doi:10.1038/srep44186. PMC 5341156. PMID 28272459. Unknown parameter |displayauthors= ignored (bantuan)
"Inhibition of human muscle-specific enolase by methylglyoxal and irreversible formation of advanced glycation end products". Journal of Enzyme Inhibition and Medicinal Chemistry. 24 (2): 356–364. April 2009. doi:10.1080/14756360802187679. PMID 18830874.
"Targeting Host Glycolysis as a Strategy for Antimalarial Development". Frontiers in Cellular and Infection Microbiology. 11: 730413. 16 September 2021. doi:10.3389/fcimb.2021.730413. PMC 8482815 Check |pmc= value (bantuan). PMID 34604112 Check |pmid= value (bantuan). Unknown parameter |displayauthors= ignored (bantuan)
"Structure-guided microbial targeting of antistaphylococcal prodrugs". eLife. 10: e66657. July 2021. doi:10.7554/eLife.66657. PMC 8318587 Check |pmc= value (bantuan). PMID 34279224. Unknown parameter |displayauthors= ignored (bantuan)
"Antimicrobial Prodrug Activation by the Staphylococcal Glyoxalase GloB". ACS Infectious Diseases. 6 (11): 3064–3075. November 2020. doi:10.1021/acsinfecdis.0c00582. PMC 8543975 Check |pmc= value (bantuan). PMID 33118347. Unknown parameter |displayauthors= ignored (bantuan)
"Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant Melanoma". Cell Reports. 33 (3): 108293. October 2020. doi:10.1016/j.celrep.2020.108293. PMC 7649750. PMID 33086062. Unknown parameter |displayauthors= ignored (bantuan)
"Functional and structural basis of E. coli enolase inhibition by SF2312: a mimic of the carbanion intermediate". Scientific Reports. 9 (1): 17106. November 2019. Bibcode:2019NatSR...917106K. doi:10.1038/s41598-019-53301-3. PMC 6863902. PMID 31745118. Unknown parameter |displayauthors= ignored (bantuan)
"The 3S Enantiomer Drives Enolase Inhibitory Activity in SF2312 and Its Analogues". Molecules. 24 (13): 2510. July 2019. doi:10.3390/molecules24132510. PMC 6651268. PMID 31324042. Unknown parameter |displayauthors= ignored (bantuan)

ncbi.nlm.nih.gov

"Molecular structure of the human muscle-specific enolase gene (ENO3)". The Biochemical Journal. 275 ( Pt 2) (Pt 2): 427–433. April 1991. doi:10.1042/bj2750427. PMC 1150071. PMID 1840492.
"Levels of enolase and other enzymes in the cerebrospinal fluid as indices of pathological change". Journal of Neurology, Neurosurgery, and Psychiatry. 44 (12): 1129–1135. December 1981. doi:10.1136/jnnp.44.12.1129. PMC 491233. PMID 7334408.
"Cerebrospinal fluid enolase in stroke". Journal of Neurology, Neurosurgery, and Psychiatry. 47 (7): 724–729. July 1984. doi:10.1136/jnnp.47.7.724. PMC 1027902. PMID 6747647.
"Passenger deletions generate therapeutic vulnerabilities in cancer". Nature. 488 (7411): 337–342. August 2012. Bibcode:2012Natur.488..337M. doi:10.1038/nature11331. PMC 3712624. PMID 22895339. Unknown parameter |displayauthors= ignored (bantuan)
"SF2312 is a natural phosphonate inhibitor of enolase". Nature Chemical Biology. 12 (12): 1053–1058. December 2016. doi:10.1038/nchembio.2195. PMC 5110371. PMID 27723749. Unknown parameter |displayauthors= ignored (bantuan)
"Functional and structural basis of E. coli enolase inhibition by SF2312: a mimic of the carbanion intermediate". Scientific Reports. 9 (1): 17106. November 2019. Bibcode:2019NatSR...917106K. doi:10.1038/s41598-019-53301-3. PMC 6863902. PMID 31745118. Unknown parameter |displayauthors= ignored (bantuan)
"The 3S Enantiomer Drives Enolase Inhibitory Activity in SF2312 and Its Analogues". Molecules. 24 (13): 2510. July 2019. doi:10.3390/molecules24132510. PMC 6651268. PMID 31324042. Unknown parameter |displayauthors= ignored (bantuan)
"An enolase inhibitor for the targeted treatment of ENO1-deleted cancers". Nature Metabolism. 2 (12): 1413–1426. December 2020. doi:10.1038/s42255-020-00313-3. PMC 7744354. PMID 33230295. Unknown parameter |displayauthors= ignored (bantuan)
"ENOblock Does Not Inhibit the Activity of the Glycolytic Enzyme Enolase". PLOS ONE. 11 (12): e0168739. 28 December 2016. Bibcode:2016PLoSO..1168739S. doi:10.1371/journal.pone.0168739. PMC 5193436. PMID 28030597.
"ENOblock, a unique small molecule inhibitor of the non-glycolytic functions of enolase, alleviates the symptoms of type 2 diabetes". Scientific Reports. 7: 44186. March 2017. Bibcode:2017NatSR...744186C. doi:10.1038/srep44186. PMC 5341156. PMID 28272459. Unknown parameter |displayauthors= ignored (bantuan)
"Targeting Host Glycolysis as a Strategy for Antimalarial Development". Frontiers in Cellular and Infection Microbiology. 11: 730413. 16 September 2021. doi:10.3389/fcimb.2021.730413. PMC 8482815 Check |pmc= value (bantuan). PMID 34604112 Check |pmid= value (bantuan). Unknown parameter |displayauthors= ignored (bantuan)
"Structure-guided microbial targeting of antistaphylococcal prodrugs". eLife. 10: e66657. July 2021. doi:10.7554/eLife.66657. PMC 8318587 Check |pmc= value (bantuan). PMID 34279224. Unknown parameter |displayauthors= ignored (bantuan)
"Antimicrobial Prodrug Activation by the Staphylococcal Glyoxalase GloB". ACS Infectious Diseases. 6 (11): 3064–3075. November 2020. doi:10.1021/acsinfecdis.0c00582. PMC 8543975 Check |pmc= value (bantuan). PMID 33118347. Unknown parameter |displayauthors= ignored (bantuan)
"Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant Melanoma". Cell Reports. 33 (3): 108293. October 2020. doi:10.1016/j.celrep.2020.108293. PMC 7649750. PMID 33086062. Unknown parameter |displayauthors= ignored (bantuan)
"Functional and structural basis of E. coli enolase inhibition by SF2312: a mimic of the carbanion intermediate". Scientific Reports. 9 (1): 17106. November 2019. Bibcode:2019NatSR...917106K. doi:10.1038/s41598-019-53301-3. PMC 6863902. PMID 31745118. Unknown parameter |displayauthors= ignored (bantuan)
"The 3S Enantiomer Drives Enolase Inhibitory Activity in SF2312 and Its Analogues". Molecules. 24 (13): 2510. July 2019. doi:10.3390/molecules24132510. PMC 6651268. PMID 31324042. Unknown parameter |displayauthors= ignored (bantuan)

rcsb.org

PDB: 2ONE; Zhang E, Brewer JM, Minor W, Carreira LA, Lebioda L (October 1997). "Mechanism of enolase: the crystal structure of asymmetric dimer enolase-2-phospho-D-glycerate/enolase-phosphoenolpyruvate at 2.0 A resolution". Biochemistry. 36 (41): 12526–12534. doi:10.1021/bi9712450. PMID 9376357.
PDB: 2XSX; Vollmar M, Krysztofinska E, Chaikuad A, Krojer T, Cocking R, Vondelft F, Bountra C, Arrowsmith CH, Weigelt J, Edwards A, Yue WW, Oppermann U (2010). "Crystal structure of human beta enolase ENOB". Protein Data Bank.

wikipedia.org

en.wikipedia.org

"Purification and properties of enolase of human erythrocytes". International Journal of Biochemistry. 5 (11–12): 845–852. November 1974. doi:10.1016/0020-711X(74)90119-0. |hdl-access= requires |hdl= (bantuan)
"Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase". Arthritis and Rheumatism. 58 (10): 3009–3019. October 2008. doi:10.1002/art.23936. PMID 18821669. Unknown parameter |displayauthors= ignored (bantuan)
"Autoantibodies against the amino terminal of alpha-enolase are a useful diagnostic marker of Hashimoto's encephalopathy". Journal of Neuroimmunology. 162 (1–2): 130–136. May 2005. doi:10.1016/j.jneuroim.2005.02.004. PMID 15833368. Unknown parameter |displayauthors= ignored (bantuan)
"A unique small molecule inhibitor of enolase clarifies its role in fundamental biological processes". ACS Chemical Biology. 8 (6): 1271–1282. 2 April 2013. doi:10.1021/cb300687k. PMID 23547795. Unknown parameter |displayauthors= ignored (bantuan)
"Structural flexibility in Trypanosoma brucei enolase revealed by X-ray crystallography and molecular dynamics". The FEBS Journal. 274 (19): 5077–5089. October 2007. doi:10.1111/j.1742-4658.2007.06027.x. PMID 17822439. Unknown parameter |displayauthors= ignored (bantuan)
"Passenger deletions generate therapeutic vulnerabilities in cancer". Nature. 488 (7411): 337–342. August 2012. Bibcode:2012Natur.488..337M. doi:10.1038/nature11331. PMC 3712624. PMID 22895339. Unknown parameter |displayauthors= ignored (bantuan)
"SF2312 is a natural phosphonate inhibitor of enolase". Nature Chemical Biology. 12 (12): 1053–1058. December 2016. doi:10.1038/nchembio.2195. PMC 5110371. PMID 27723749. Unknown parameter |displayauthors= ignored (bantuan)
"Functional and structural basis of E. coli enolase inhibition by SF2312: a mimic of the carbanion intermediate". Scientific Reports. 9 (1): 17106. November 2019. Bibcode:2019NatSR...917106K. doi:10.1038/s41598-019-53301-3. PMC 6863902. PMID 31745118. Unknown parameter |displayauthors= ignored (bantuan)
"The 3S Enantiomer Drives Enolase Inhibitory Activity in SF2312 and Its Analogues". Molecules. 24 (13): 2510. July 2019. doi:10.3390/molecules24132510. PMC 6651268. PMID 31324042. Unknown parameter |displayauthors= ignored (bantuan)
"An enolase inhibitor for the targeted treatment of ENO1-deleted cancers". Nature Metabolism. 2 (12): 1413–1426. December 2020. doi:10.1038/s42255-020-00313-3. PMC 7744354. PMID 33230295. Unknown parameter |displayauthors= ignored (bantuan)
"ENOblock, a unique small molecule inhibitor of the non-glycolytic functions of enolase, alleviates the symptoms of type 2 diabetes". Scientific Reports. 7: 44186. March 2017. Bibcode:2017NatSR...744186C. doi:10.1038/srep44186. PMC 5341156. PMID 28272459. Unknown parameter |displayauthors= ignored (bantuan)
"Targeting Host Glycolysis as a Strategy for Antimalarial Development". Frontiers in Cellular and Infection Microbiology. 11: 730413. 16 September 2021. doi:10.3389/fcimb.2021.730413. PMC 8482815 Check |pmc= value (bantuan). PMID 34604112 Check |pmid= value (bantuan). Unknown parameter |displayauthors= ignored (bantuan)
"Structure-guided microbial targeting of antistaphylococcal prodrugs". eLife. 10: e66657. July 2021. doi:10.7554/eLife.66657. PMC 8318587 Check |pmc= value (bantuan). PMID 34279224. Unknown parameter |displayauthors= ignored (bantuan)
"Antimicrobial Prodrug Activation by the Staphylococcal Glyoxalase GloB". ACS Infectious Diseases. 6 (11): 3064–3075. November 2020. doi:10.1021/acsinfecdis.0c00582. PMC 8543975 Check |pmc= value (bantuan). PMID 33118347. Unknown parameter |displayauthors= ignored (bantuan)
"Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant Melanoma". Cell Reports. 33 (3): 108293. October 2020. doi:10.1016/j.celrep.2020.108293. PMC 7649750. PMID 33086062. Unknown parameter |displayauthors= ignored (bantuan)
"Functional and structural basis of E. coli enolase inhibition by SF2312: a mimic of the carbanion intermediate". Scientific Reports. 9 (1): 17106. November 2019. Bibcode:2019NatSR...917106K. doi:10.1038/s41598-019-53301-3. PMC 6863902. PMID 31745118. Unknown parameter |displayauthors= ignored (bantuan)
"The 3S Enantiomer Drives Enolase Inhibitory Activity in SF2312 and Its Analogues". Molecules. 24 (13): 2510. July 2019. doi:10.3390/molecules24132510. PMC 6651268. PMID 31324042. Unknown parameter |displayauthors= ignored (bantuan)